期刊文献+

不同期别子宫内膜异位症对卵巢储备功能的影响 被引量:4

The Effect of Different Stages Endometriosis on Ovarian Reserve
下载PDF
导出
摘要 目的通过检测血清抗苗勒管激素(AMH)水平以探讨不同期别子宫内膜异位症对卵巢储备功能的影响。方法收集我院2016年1月—2018年4月收治的子宫内膜异位症患者80例作为观察组,其中轻中度组(Ⅰ~Ⅱ期)40例,重度组(Ⅲ~Ⅳ期)40例;同期非子宫内膜异位症单纯行卵巢畸胎瘤剥除术或子宫肌瘤剔除术的患者44例作为对照组,获取术前血清AMH检测值及临床资料。AMH测定采用酶联免疫吸附试验,对3组结果进行比较。结果对照组患者的AMH(6.90±0.56)μg/L,高于轻中度组的(5.15±0.59)μg/L和重度组患者的(2.86±0.23)μg/L,三组比较差异具有统计学意义,P<0.05。结论针对不同程度子宫内膜异位症患者血清AMH水平的测定和比较,可以看出血清AMH水平可以作为评估子宫内膜异位症病变严重程度的指标。 Objective To measure AMH serum levels in order to demonstrate the effect of different stages endometriosis on ovarian reserve.Methods 80 cases of endometriosis admitted to our hospital from January 2016 to April 2018 were selected as the observation group.40 cases in mild and moderate group(Ⅰ to Ⅱ),40 cases in severe group(Ⅲ to Ⅳ stage).In the same period,44 patients with non endometriosis treated with ovarian teratoma or myomectomy were selected as the control group,and the preoperative serum AMH and clinical data were obtained.AMH was determined by enzyme-linked immunosorbent assay(ELISA),and the results of three groups were compared.Results The level of AMH was(6.90±0.56) μg/L in the control group,which was higher than(5.15±0.59) μg/L in the mild to moderate group and(2.86±0.23) μg/L in the severe group.The difference among the three groups was statistically significant,P〈 0.05.Conclusion From the comparison of serum AMH levels of different stages EMS with the control group,we can see that AMH could be used to access the seriousness of EMS.
作者 陈瑜沙 CHEN Yusha(Obstetrics and Gynecology Department,Fujian Provincial Maternity and Children's Hospital/Affiliated Hospital of Fujian Medical University,Fuzhou Fujian 350001,China)
出处 《中国卫生标准管理》 2018年第16期34-35,共2页 China Health Standard Management
关键词 抗苗勒管激素 卵巢储备功能 子宫内膜异位症 性激素 不同期别 内分泌 AMH ovarian reserve ems sex hormone different stages endocrine
  • 相关文献

参考文献5

二级参考文献93

  • 1沈健,冯云,黄晓燕.控制性促排卵早期血清抑制素B的变化及意义[J].生殖与避孕,2005,25(10):623-626. 被引量:7
  • 2夏天,罗颂平.抗苗勒激素与卵巢储备力[J].生殖与避孕,2006,26(11):684-688. 被引量:6
  • 3Baird DT, Collins J, Egozcue J, et al. Fertility and ageing [J]. Hum Reprod Update,2005,11:261-276.
  • 4Practice Committee of the American Society for Reproductive Medicine. Aging and inferitility in women [J]. Fertil {ertil, 2006,86(Ssupp11):S248-252.
  • 5Caroppo E, Matteo M, Schonauer LM, et al. Basal FSH concentration as a predictor of IVF outcome in older women undergoing stimulation with GnRH antagonis[J/OL. Reprod Biomed Online, 2006,13 : 815-820.
  • 6luna M, Grunfeld L, Mukherjee T, et al. Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization [J]. Fertil Steril, 2007,87 : 782-787.
  • 7Thum MY, Kalu E, Abdalla H. Elevated basal FSH andembryo qua[itytlessons from extended culture embryos:raised FSH and blastocyst quality [J]. J Assist Reprod Genet, 2009,26:313-318.
  • 8Roberts JE, Spandorfer S, Fasouliotis SJ, et al. Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization [J]. Fertil Steril, 2005, 83: 37-41.
  • 9Bancsi LF, Broekmans FJ, Mol BW, et al. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis [J]. Fertil Steril, 2003, 79: 1091-1100.
  • 10Martin JS, Nisker JA, Tummon IS, et al Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels [J]. FertilSteril, 1996,65 : 1238-1240.

共引文献94

同被引文献58

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部